{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T12:17:57Z","timestamp":1795177077983,"version":"4.10.3"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T00:00:00Z","timestamp":1731024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-53564-z","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T08:25:56Z","timestamp":1731054356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["FNDC4 alleviates cardiac ischemia\/reperfusion injury through facilitating HIF1\u03b1-dependent cardiomyocyte survival and angiogenesis in male mice"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5941-3921","authenticated-orcid":false,"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Peng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7942-9484","authenticated-orcid":false,"given":"Wen-Sheng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Jia","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4330-4855","authenticated-orcid":false,"given":"Can","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,8]]},"reference":[{"key":"53564_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","volume":"73","author":"SM Davidson","year":"2019","unstructured":"Davidson, S. M. et al. Multitarget strategies to reduce myocardial ischemia\/reperfusion injury: JACC review topic of the week. J. Am. Coll. Cardiol. 73, 89\u201399 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53564_CR2","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1161\/01.CIR.0000101917.80668.E1","volume":"108","author":"T Reffelmann","year":"2003","unstructured":"Reffelmann, T., Hale, S. L., Dow, J. S. & Kloner, R. A. No-reflow phenomenon persists long-term after ischemia\/reperfusion in the rat and predicts infarct expansion. Circulation 108, 2911\u20132917 (2003).","journal-title":"Circulation"},{"key":"53564_CR3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1161\/CIRCRESAHA.107.153346","volume":"101","author":"M Bosch-Marce","year":"2007","unstructured":"Bosch-Marce, M. et al. Effects of aging and hypoxia-inducible factor-1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ. Res. 101, 1310\u20131318 (2007).","journal-title":"Circ. Res."},{"key":"53564_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/CIRCRESAHA.117.311983","volume":"122","author":"C Fu","year":"2018","unstructured":"Fu, C. et al. Inositol polyphosphate multikinase inhibits angiogenesis via inositol pentakisphosphate-induced HIF-1alpha degradation. Circ. Res. 122, 457\u2013472 (2018).","journal-title":"Circ. Res."},{"key":"53564_CR5","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/cdd.2008.13","volume":"15","author":"G Loor","year":"2008","unstructured":"Loor, G. & Schumacker, P. T. Role of hypoxia-inducible factor in cell survival during myocardial ischemia-reperfusion. Cell Death Differ. 15, 686\u2013690 (2008).","journal-title":"Cell Death Differ."},{"key":"53564_CR6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.molcel.2010.09.022","volume":"40","author":"AJ Majmundar","year":"2010","unstructured":"Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell. 40, 294\u2013309 (2010).","journal-title":"Mol. Cell."},{"key":"53564_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/cvr\/cvu177","volume":"104","author":"J Gu","year":"2014","unstructured":"Gu, J. et al. SENP1 protects against myocardial ischaemia\/reperfusion injury via a HIF1alpha-dependent pathway. Cardiovasc. Res. 104, 83\u201392 (2014).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/32925","volume":"392","author":"WG An","year":"1998","unstructured":"An, W. G. et al. Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392, 405\u2013408 (1998).","journal-title":"Nature"},{"key":"53564_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39159-0","volume":"14","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Tisp40 prevents cardiac ischemia\/reperfusion injury through the hexosamine biosynthetic pathway in male mice. Nat. Commun. 14, 3383 (2023).","journal-title":"Nat. Commun."},{"key":"53564_CR10","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/cvr\/cvae077","volume":"120","author":"M Hu","year":"2024","unstructured":"Hu, M. et al. Isthmin-1 alleviates cardiac ischaemia\/reperfusion injury through cGMP-PKG signalling pathway. Cardiovasc. Res. 120, 1051\u20131064 (2024).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR11","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/REP-22-0037","volume":"164","author":"M Daudon","year":"2022","unstructured":"Daudon, M., Bigot, Y., Dupont, J. & Price, C. A. Irisin and the fibronectin type III domain-containing family: structure, signaling and role in female reproduction. Reproduction 164, R1\u2013R9 (2022).","journal-title":"Reproduction"},{"key":"53564_CR12","doi-asserted-by":"publisher","first-page":"109805","DOI":"10.1016\/j.cellsig.2020.109805","volume":"76","author":"X Zhang","year":"2020","unstructured":"Zhang, X., Hu, C., Yuan, Y. P., Ma, Z. G. & Tang, Q. Z. A brief overview about the physiology of fibronectin type III domain-containing 5. Cell. Signal. 76, 109805 (2020).","journal-title":"Cell. Signal."},{"key":"53564_CR13","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41401-020-00557-5","volume":"42","author":"X Zhang","year":"2021","unstructured":"Zhang, X., Hu, C., Wu, H. M., Ma, Z. G. & Tang, Q. Z. Fibronectin type III domain-containing 5 in cardiovascular and metabolic diseases: a promising biomarker and therapeutic target. Acta Pharmacol. Sin. 42, 1390\u20131400 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"53564_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1073\/pnas.0507467103","volume":"103","author":"M Sato","year":"2006","unstructured":"Sato, M. et al. Identification of a receptor-independent activator of G protein signaling (AGS8) in ischemic heart and its interaction with Gbetagamma. Proc. Natl Acad. Sci. USA. 103, 797\u2013802 (2006).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"53564_CR15","doi-asserted-by":"publisher","first-page":"31431","DOI":"10.1074\/jbc.M109.014068","volume":"284","author":"M Sato","year":"2009","unstructured":"Sato, M. et al. Activator of G protein signaling 8 (AGS8) is required for hypoxia-induced apoptosis of cardiomyocytes: role of G betagamma and connexin 43 (CX43). J. Biol. Chem. 284, 31431\u201331440 (2009).","journal-title":"J. Biol. Chem."},{"key":"53564_CR16","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.freeradbiomed.2022.10.322","volume":"193","author":"Y You","year":"2022","unstructured":"You, Y. et al. FNDC3B protects steatosis and ferroptosis via the AMPK pathway in alcoholic fatty liver disease. Free Radic. Biol. Med. 193, 808\u2013819 (2022).","journal-title":"Free Radic. Biol. Med."},{"key":"53564_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11777-7","volume":"10","author":"V Garikipati","year":"2019","unstructured":"Garikipati, V. et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS\/VEGF-A axis. Nat. Commun. 10, 4317 (2019).","journal-title":"Nat. Commun."},{"key":"53564_CR18","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostrom","year":"2012","unstructured":"Bostrom, P. et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463\u2013468 (2012).","journal-title":"Nature"},{"key":"53564_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1161\/CIRCHEARTFAILURE.112.969543","volume":"5","author":"SH Lecker","year":"2012","unstructured":"Lecker, S. H. et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ. Heart Fail. 5, 812\u2013818 (2012).","journal-title":"Circ. Heart Fail."},{"key":"53564_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.yjmcc.2018.07.250","volume":"121","author":"RL Li","year":"2018","unstructured":"Li, R. L. et al. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway. J. Mol. Cell. Cardiol. 121, 242\u2013255 (2018).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"53564_CR21","doi-asserted-by":"publisher","first-page":"e13556","DOI":"10.1111\/acel.13556","volume":"21","author":"C Hu","year":"2022","unstructured":"Hu, C. et al. Fibronectin type III domain-containing 5 improves aging-related cardiac dysfunction in mice. Aging Cell. 21, e13556 (2022).","journal-title":"Aging Cell."},{"key":"53564_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41418-019-0372-z","volume":"27","author":"X Zhang","year":"2020","unstructured":"Zhang, X. et al. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Cell Death Differ. 27, 540\u2013555 (2020).","journal-title":"Cell Death Differ."},{"key":"53564_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11314","volume":"7","author":"M Bosma","year":"2016","unstructured":"Bosma, M. et al. FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice. Nat. Commun. 7, 11314 (2016).","journal-title":"Nat. Commun."},{"key":"53564_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22579-1","volume":"12","author":"A Georgiadi","year":"2021","unstructured":"Georgiadi, A. et al. Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue. Nat. Commun. 12, 2999 (2021).","journal-title":"Nat. Commun."},{"key":"53564_CR25","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1016\/j.jacc.2005.08.045","volume":"46","author":"M Kido","year":"2005","unstructured":"Kido, M. et al. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. J. Am. Coll. Cardiol. 46, 2116\u20132124 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53564_CR26","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1021\/acs.biochem.5b01341","volume":"55","author":"I Prudovsky","year":"2016","unstructured":"Prudovsky, I. et al. Folding of fibroblast growth factor 1 Is critical for its nonclassical release. Biochemistry 55, 1159\u20131167 (2016).","journal-title":"Biochemistry"},{"key":"53564_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1074\/mcp.M113.035600","volume":"13","author":"L Fagerberg","year":"2014","unstructured":"Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Proteom. 13, 397\u2013406 (2014).","journal-title":"Mol. Cell. Proteom."},{"key":"53564_CR28","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature13992","volume":"515","author":"F Yue","year":"2014","unstructured":"Yue, F. et al. A comparative encyclopedia of DNA elements in the mouse genome. Nature 515, 355\u2013364 (2014).","journal-title":"Nature"},{"key":"53564_CR29","doi-asserted-by":"publisher","first-page":"E3325","DOI":"10.1073\/pnas.1412840111","volume":"111","author":"ME Hubbi","year":"2014","unstructured":"Hubbi, M. E. et al. Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1alpha to promote cell-cycle progression. Proc. Natl Acad. Sci. USA. 111, E3325\u2013E3334 (2014).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"53564_CR30","doi-asserted-by":"publisher","first-page":"10703","DOI":"10.1074\/jbc.M112.414771","volume":"288","author":"ME Hubbi","year":"2013","unstructured":"Hubbi, M. E. et al. Chaperone-mediated autophagy targets hypoxia-inducible factor-1alpha (HIF-1alpha) for lysosomal degradation. J. Biol. Chem. 288, 10703\u201310714 (2013).","journal-title":"J. Biol. Chem."},{"key":"53564_CR31","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/ncb2954","volume":"16","author":"Y Fan","year":"2014","unstructured":"Fan, Y. et al. Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1alpha accumulation. Nat. Cell Biol. 16, 445\u2013456 (2014).","journal-title":"Nat. Cell Biol."},{"key":"53564_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/01.CIR.0000078635.89229.8A","volume":"108","author":"Z Cai","year":"2003","unstructured":"Cai, Z. et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108, 79\u201385 (2003).","journal-title":"Circulation"},{"key":"53564_CR33","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.RES.0000197816.63513.27","volume":"98","author":"R Natarajan","year":"2006","unstructured":"Natarajan, R., Salloum, F. N., Fisher, B. J., Kukreja, R. C. & Fowler, A. R. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ. Res. 98, 133\u2013140 (2006).","journal-title":"Circ. Res."},{"key":"53564_CR34","doi-asserted-by":"publisher","first-page":"11185","DOI":"10.1074\/jbc.M110.186809","volume":"286","author":"M Holscher","year":"2011","unstructured":"Holscher, M. et al. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J. Biol. Chem. 286, 11185\u201311194 (2011).","journal-title":"J. Biol. Chem."},{"key":"53564_CR35","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cvr\/cvu172","volume":"104","author":"SG Ong","year":"2014","unstructured":"Ong, S. G. et al. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. Cardiovasc. Res. 104, 24\u201336 (2014).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR36","doi-asserted-by":"publisher","first-page":"H867","DOI":"10.1152\/ajpheart.00875.2014","volume":"309","author":"G Nanayakkara","year":"2015","unstructured":"Nanayakkara, G. et al. Cardioprotective HIF-1alpha-frataxin signaling against ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 309, H867\u2013H879 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"53564_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1718-7","volume":"10","author":"FY Liu","year":"2019","unstructured":"Liu, F. Y. et al. TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis. 10, 480 (2019).","journal-title":"Cell Death Dis."},{"key":"53564_CR38","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1161\/CIRCULATIONAHA.110.014019","volume":"124","author":"M Huang","year":"2011","unstructured":"Huang, M. et al. Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction. Circulation 124, S46\u2013S54 (2011).","journal-title":"Circulation"},{"key":"53564_CR39","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1161\/01.RES.0000102937.50486.1B","volume":"93","author":"BD Kelly","year":"2003","unstructured":"Kelly, B. D. et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ. Res. 93, 1074\u20131081 (2003).","journal-title":"Circ. Res."},{"key":"53564_CR40","doi-asserted-by":"publisher","first-page":"12787","DOI":"10.1074\/jbc.M117.784553","volume":"292","author":"BA Rose","year":"2017","unstructured":"Rose, B. A. et al. Cardiac myocyte p38alpha kinase regulates angiogenesis via myocyte-endothelial cell cross-talk during stress-induced remodeling in the heart. J. Biol. Chem. 292, 12787\u201312800 (2017).","journal-title":"J. Biol. Chem."},{"key":"53564_CR41","doi-asserted-by":"publisher","first-page":"11754","DOI":"10.7150\/thno.43163","volume":"10","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Cardiomyocyte-derived small extracellular vesicles can signal eNOS activation in cardiac microvascular endothelial cells to protect against Ischemia\/Reperfusion injury. Theranostics 10, 11754\u201311774 (2020).","journal-title":"Theranostics"},{"key":"53564_CR42","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.ymthe.2022.03.002","volume":"30","author":"L Ottaviani","year":"2022","unstructured":"Ottaviani, L. et al. Intercellular transfer of miR-200c-3p impairs the angiogenic capacity of cardiac endothelial cells. Mol. Ther. 30, 2257\u20132273 (2022).","journal-title":"Mol. Ther."},{"key":"53564_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20361-3","volume":"12","author":"MM Gladka","year":"2021","unstructured":"Gladka, M. M. et al. Cardiomyocytes stimulate angiogenesis after ischemic injury in a ZEB2-dependent manner. Nat. Commun. 12, 84 (2021).","journal-title":"Nat. Commun."},{"key":"53564_CR44","doi-asserted-by":"publisher","first-page":"3936257","DOI":"10.1155\/2018\/3936257","volume":"2018","author":"ZT Lv","year":"2018","unstructured":"Lv, Z. T. et al. FNDC4 inhibits RANKL-induced osteoclast formation by suppressing NF-kappaB activation and CXCL10 expression. Biomed. Res. Int. 2018, 3936257 (2018).","journal-title":"Biomed. Res. Int."},{"key":"53564_CR45","doi-asserted-by":"publisher","first-page":"154261","DOI":"10.1016\/j.metabol.2020.154261","volume":"108","author":"G Fruhbeck","year":"2020","unstructured":"Fruhbeck, G. et al. FNDC4, a novel adipokine that reduces lipogenesis and promotes fat browning in human visceral adipocytes. Metab. Clin. Exp. 108, 154261 (2020).","journal-title":"Metab. Clin. Exp."},{"key":"53564_CR46","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1161\/ATVBAHA.108.165738","volume":"28","author":"E Wallgard","year":"2008","unstructured":"Wallgard, E. et al. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler. Thromb. Vasc. Biol. 28, 1469\u20131476 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"53564_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s10456-019-09674-0","volume":"22","author":"C Niaudet","year":"2019","unstructured":"Niaudet, C. et al. Adgrf5 contributes to patterning of the endothelial deep layer in retina. Angiogenesis 22, 491\u2013505 (2019).","journal-title":"Angiogenesis"},{"key":"53564_CR48","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3389\/fphys.2013.00247","volume":"4","author":"N Itoh","year":"2013","unstructured":"Itoh, N. & Ohta, H. Pathophysiological roles of FGF signaling in the heart. Front. Physiol. 4, 247 (2013).","journal-title":"Front. Physiol."},{"key":"53564_CR49","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(02)08937-7","volume":"359","author":"RJ Lederman","year":"2002","unstructured":"Lederman, R. J. et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial. Lancet 359, 2053\u20132058 (2002).","journal-title":"Lancet"},{"key":"53564_CR50","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/hc0802.104407","volume":"105","author":"M Simons","year":"2002","unstructured":"Simons, M. et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation 105, 788\u2013793 (2002).","journal-title":"Circulation"},{"key":"53564_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1161\/01.RES.72.1.7","volume":"72","author":"GL Engelmann","year":"1993","unstructured":"Engelmann, G. L., Dionne, C. A. & Jaye, M. C. Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. Circ. Res. 72, 7\u201319 (1993).","journal-title":"Circ. Res."},{"key":"53564_CR52","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.jacc.2004.05.067","volume":"44","author":"M Palmen","year":"2004","unstructured":"Palmen, M. et al. Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism. J. Am. Coll. Cardiol. 44, 1113\u20131123 (2004).","journal-title":"J. Am. Coll. Cardiol."},{"key":"53564_CR53","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1161\/01.RES.87.3.207","volume":"87","author":"B Fernandez","year":"2000","unstructured":"Fernandez, B. et al. Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circ. Res. 87, 207\u2013213 (2000).","journal-title":"Circ. Res."},{"key":"53564_CR54","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1021\/acsbiomaterials.6b00509","volume":"3","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. Fibroblast growth factor-1 released from a heparin coacervate improves cardiac function in a mouse myocardial infarction model. Acs Biomater. Sci. Eng. 3, 1988\u20131999 (2017).","journal-title":"Acs Biomater. Sci. Eng."},{"key":"53564_CR55","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S0008-6363(02)00494-7","volume":"55","author":"A Buehler","year":"2002","unstructured":"Buehler, A. et al. Angiogenesis-independent cardioprotection in FGF-1 transgenic mice. Cardiovasc. Res. 55, 768\u2013777 (2002).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR56","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/cvr\/cvab248","volume":"118","author":"G Li","year":"2022","unstructured":"Li, G. et al. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling. Cardiovasc. Res. 118, 2139\u20132151 (2022).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-017-0123-3","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKalpha\/Smad3 signaling. Cell Death Dis. 9, 102 (2018).","journal-title":"Cell Death Dis."},{"key":"53564_CR58","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.apsb.2019.03.003","volume":"9","author":"C Hu","year":"2019","unstructured":"Hu, C. et al. Matrine attenuates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via maintaining AMPKalpha\/UCP2 pathway. Acta Pharm. Sin. B. 9, 690\u2013701 (2019).","journal-title":"Acta Pharm. Sin. B."},{"key":"53564_CR59","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.124","volume":"10","author":"C Hu","year":"2020","unstructured":"Hu, C. et al. Osteocrin attenuates inflammation, oxidative stress, apoptosis, and cardiac dysfunction in doxorubicin-induced cardiotoxicity. Clin. Transl. Med. 10, e124 (2020).","journal-title":"Clin. Transl. Med."},{"key":"53564_CR60","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/CIRCULATIONAHA.119.043545","volume":"142","author":"X Hua","year":"2020","unstructured":"Hua, X. et al. Single-cell RNA sequencing to dissect the immunological network of autoimmune myocarditis. Circulation 142, 384\u2013400 (2020).","journal-title":"Circulation"},{"key":"53564_CR61","doi-asserted-by":"publisher","first-page":"101747","DOI":"10.1016\/j.redox.2020.101747","volume":"37","author":"C Hu","year":"2020","unstructured":"Hu, C. et al. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP\/PKA\/SIRT1 pathway. Redox Biol. 37, 101747 (2020).","journal-title":"Redox Biol."},{"key":"53564_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40639-6","volume":"14","author":"ZG Ma","year":"2023","unstructured":"Ma, Z. G. et al. IRX2 regulates angiotensin II-induced cardiac fibrosis by transcriptionally activating EGR1 in male mice. Nat. Commun. 14, 4967 (2023).","journal-title":"Nat. Commun."},{"key":"53564_CR63","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41401-020-0473-8","volume":"42","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Matrine attenuates pathological cardiac fibrosis via RPS5\/p38 in mice. Acta Pharmacol. Sin. 42, 573\u2013584 (2021).","journal-title":"Acta Pharmacol. Sin."},{"key":"53564_CR64","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s10565-021-09581-5","volume":"37","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Endothelial ERG alleviates cardiac fibrosis via blocking endothelin-1-dependent paracrine mechanism. Cell Biol. Toxicol. 37, 873\u2013890 (2021).","journal-title":"Cell Biol. Toxicol."},{"key":"53564_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03922-2","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity. Cell Death Dis. 12, 624 (2021).","journal-title":"Cell Death Dis."},{"key":"53564_CR66","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/cvr\/cvy279","volume":"115","author":"ZG Ma","year":"2019","unstructured":"Ma, Z. G. et al. C1q-tumour necrosis factor-related protein-3 exacerbates cardiac hypertrophy in mice. Cardiovasc. Res. 115, 1067\u20131077 (2019).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16026-w","volume":"11","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Adipocyte Piezo1 mediates obesogenic adipogenesis through the FGF1\/FGFR1 signaling pathway in mice. Nat. Commun. 11, 2303 (2020).","journal-title":"Nat. Commun."},{"key":"53564_CR68","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1093\/cvr\/cvz236","volume":"116","author":"B Krist","year":"2020","unstructured":"Krist, B. et al. miR-378a influences vascularization in skeletal muscles. Cardiovasc. Res. 116, 1386\u20131397 (2020).","journal-title":"Cardiovasc. Res."},{"key":"53564_CR69","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1073\/pnas.83.9.2919","volume":"83","author":"BA Kruskal","year":"1986","unstructured":"Kruskal, B. A., Shak, S. & Maxfield, F. R. Spreading of human neutrophils is immediately preceded by a large increase in cytoplasmic free calcium. Proc. Natl Acad. Sci. USA. 83, 2919\u20132923 (1986).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"53564_CR70","doi-asserted-by":"publisher","first-page":"556","DOI":"10.7150\/ijbs.29907","volume":"15","author":"X Zhang","year":"2019","unstructured":"Zhang, X. et al. Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity. Int. J. Biol. Sci. 15, 556\u2013567 (2019).","journal-title":"Int. J. Biol. Sci."},{"key":"53564_CR71","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/CS20180160","volume":"132","author":"ZG Ma","year":"2018","unstructured":"Ma, Z. G. et al. A77 1726 (leflunomide) blocks and reverses cardiac hypertrophy and fibrosis in mice. Clin. Sci. 132, 685\u2013699 (2018).","journal-title":"Clin. Sci."},{"key":"53564_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37832-y","volume":"14","author":"B Yu","year":"2023","unstructured":"Yu, B. et al. Extracellular vesicles engineering by silicates-activated endothelial progenitor cells for myocardial infarction treatment in male mice. Nat. Commun. 14, 2094 (2023).","journal-title":"Nat. Commun."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53564-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53564-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53564-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T10:04:03Z","timestamp":1731060243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-53564-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,8]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["53564"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-53564-z","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,8]]},"assertion":[{"value":"7 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9667"}}